Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.71)
# 3,394
Out of 5,084 analysts
207
Total ratings
22.17%
Success rate
-7.22%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $0.96 | +840.24% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.38 | +1,978.46% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.29 | +259.51% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.35 | +196.27% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $3.32 | -39.76% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $7.64 | +2,517.80% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.43 | +681.89% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.70 | +1,138.94% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.30 | +1,053.85% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $3.74 | +14,885.68% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $5.97 | +1,910.05% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.74 | +493.47% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.02 | +1,385.66% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.84 | +177.98% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.60 | +903.13% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.98 | +515.38% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.26 | +7,836.51% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.34 | +5,209.73% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.21 | +807.03% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.50 | +286,263.64% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $17.48 | +2,760.41% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $27.18 | +783.00% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.40 | +5,614.29% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $5.41 | +27,621.31% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $9.34 | +85,553.10% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.26 | +454.06% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.91 | +1,470.68% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.79 | +735.07% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $6.29 | +186.17% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $6.34 | -21.14% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $10.91 | +13,098.78% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $66.71 | -64.02% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.14 | +299,900.00% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.18 | +1,610,069.49% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $0.96
Upside: +840.24%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.38
Upside: +1,978.46%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.29
Upside: +259.51%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.35
Upside: +196.27%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.32
Upside: -39.76%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $7.64
Upside: +2,517.80%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.43
Upside: +681.89%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.70
Upside: +1,138.94%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.30
Upside: +1,053.85%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $3.74
Upside: +14,885.68%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $5.97
Upside: +1,910.05%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.74
Upside: +493.47%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $2.02
Upside: +1,385.66%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.84
Upside: +177.98%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $1.60
Upside: +903.13%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.98
Upside: +515.38%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.26
Upside: +7,836.51%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.34
Upside: +5,209.73%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.21
Upside: +807.03%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.50
Upside: +286,263.64%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $17.48
Upside: +2,760.41%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $27.18
Upside: +783.00%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.40
Upside: +5,614.29%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $5.41
Upside: +27,621.31%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $9.34
Upside: +85,553.10%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.26
Upside: +454.06%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.91
Upside: +1,470.68%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.79
Upside: +735.07%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $6.29
Upside: +186.17%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $6.34
Upside: -21.14%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $10.91
Upside: +13,098.78%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $66.71
Upside: -64.02%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.14
Upside: +299,900.00%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.18
Upside: +1,610,069.49%